Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Hyperbilirubinemia, Neonatal MeSH Descriptor Data 2025


MeSH Heading
Hyperbilirubinemia, Neonatal
Tree Number(s)
C16.614.451
C23.550.429.249
Unique ID
D051556
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D051556
Annotation
check the tag, INFANT, NEWBORN
Scope Note
Accumulation of BILIRUBIN, a breakdown product of HEME PROTEINS, in the BLOOD during the first weeks of life. This may lead to NEONATAL JAUNDICE. The excess bilirubin may exist in the unconjugated (indirect) or the conjugated (direct) form. The condition may be self-limiting (PHYSIOLOGICAL NEONATAL JAUNDICE) or pathological with toxic levels of bilirubin.
Entry Term(s)
Direct Hyperbilirubinemia, Neonatal
Hyperbilirubinemia During Infancy
Indirect Hyperbilirubinemia, Neonatal
Neonatal Hyperbilirubinemia
NLM Classification #
WS 421
Previous Indexing
Jaundice, Neonatal (1965-2005)
See Also
Jaundice, Neonatal
Public MeSH Note
2006; see JAUNDICE, NEONATAL 1976-2005
History Note
2006; use JAUNDICE, NEONATAL 1976-2005
Date Established
2006/01/01
Date of Entry
2005/06/30
Revision Date
2010/06/25
Hyperbilirubinemia, Neonatal Preferred
Direct Hyperbilirubinemia, Neonatal Narrower
Indirect Hyperbilirubinemia, Neonatal Narrower
page delivered in 0.15s